Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

InnovationQuarter

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 71
Average round size
info
The average size of a deal this fund participated in
$6M
Portfolio companies 51
Rounds per year 7.10
Lead investments 4
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.28
Exits 5
Key employees 17
Stages of investment
Early Stage Venture
Late Stage Venture
Seed

Areas of investment

  • Software
  • Information Technology
  • Health Care
  • Manufacturing
  • Biotechnology
Summary

InnovationQuarter appeared to be the Corporate Investor, which was created in 2014. The company was established in Europe in The Netherlands. The main department of described Corporate Investor is located in the The Hague.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the InnovationQuarter, startups are often financed by HPE Growth, EASME - EU Executive Agency for SMEs, Skuli Mogensen. The meaningful sponsors for the fund in investment in the same round are Vesalius Biocapital Partners, S.R.I.W., Rabobank. In the next rounds fund is usually obtained by EASME - EU Executive Agency for SMEs, Sambrinvest, SFPI-FPIM.

Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - The Netherlands. The fund has no exact preference in some founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight Cybersprint, Doculayer, LeydenJar Technologies. Among the most successful fund investment fields, there are Oil and Gas, Risk Management.

Speaking about the real fund results, this Corporate Investor is 2 percentage points less often commits exit comparing to other organizations. The fund is generally included in 2-6 deals every year. Opposing the other organizations, this InnovationQuarter works on 24 percentage points less the average amount of lead investments. The usual things for fund are deals in the range of 1 - 5 millions dollars. The top activity for fund was in 2017.

Read more

Funds with similar focus

Funds from The Netherlands
Funds with similar focus located in The Netherlands:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Abra California, Mountain View, United States
AWE net Chester Heights, Pennsylvania, United States
Debut Capital -
DVI Equity Partners Arizona, Tucson, United States
FireStarter Fund Chicago, Illinois, United States
Granite Properties Plano, Texas, United States
LightPath Capital California, Santa Monica, United States
Ningbo Ruihui Touzi China, Ningbo, Zhejiang
obopay Bangalore, India, Karnataka

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Q*Bird B.V.

$2M28 May 2024 Delft, Zuid-Holland, The Netherlands

AquaBattery

Battery
Energy
Renewable Energy
$7M22 Apr 2024 Zuid-Holland, South Holland, Netherlands

TheyDo

Consulting
Software
$36M14 Mar 2024 Amsterdam, North Holland, Netherlands

Spotr.ai

Artificial Intelligence
Big Data
Information Technology
Software
$5M23 Jan 2024 Den Haag, Zuid-Holland, The Netherlands

Synerkine Pharma

Biotechnology
Health Care
$6M12 Oct 2023 Utrecht, Utrecht, Netherlands

Villari

Health Care
Medical
$2M08 Aug 2023 Delft, Zuid-Holland, The Netherlands

Delta Diagnostics

Management Consulting
$6M09 May 2023 Bengaluru, Karnataka, India

Qualinx

Semiconductor
$9M21 Feb 2023 Delft, Zuid-Holland, The Netherlands

TheyDo

Consulting
Software
$14M13 Dec 2022 Amsterdam, North Holland, Netherlands

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent InnovationQuarter?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 71
Average round size 6M
Rounds per year 7.10
Peak activity year 2016
Lead investments 4
Follow on index 0.28
Exits 5
Group Appearance index 0.79

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Q*Bird B.V.

$2M28 May 2024 Delft, Zuid-Holland, The Netherlands

AquaBattery

Battery
Energy
Renewable Energy
$7M22 Apr 2024 Zuid-Holland, South Holland, Netherlands

TheyDo

Consulting
Software
$36M14 Mar 2024 Amsterdam, North Holland, Netherlands

Spotr.ai

Artificial Intelligence
Big Data
Information Technology
Software
$5M23 Jan 2024 Den Haag, Zuid-Holland, The Netherlands

Synerkine Pharma

Biotechnology
Health Care
$6M12 Oct 2023 Utrecht, Utrecht, Netherlands

Villari

Health Care
Medical
$2M08 Aug 2023 Delft, Zuid-Holland, The Netherlands

Delta Diagnostics

Management Consulting
$6M09 May 2023 Bengaluru, Karnataka, India

Qualinx

Semiconductor
$9M21 Feb 2023 Delft, Zuid-Holland, The Netherlands

TheyDo

Consulting
Software
$14M13 Dec 2022 Amsterdam, North Holland, Netherlands
Crunchbase icon

Content report

The following text will be sent to our editors: